Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
---|
05/03/2012 | US20120107413 Pre-natal mesenchymal stem cells |
05/03/2012 | US20120107409 Preparation and use of fish skin fermentation product |
05/03/2012 | US20120107400 Sustained release composition of theraputic agent |
05/03/2012 | US20120107397 Pharmaceutical compositions of valsartan |
05/03/2012 | US20120107380 Methods of saponifying xanthophyll esters and isolating xanthophylls |
05/03/2012 | US20120107328 Gamma secretase modulators |
05/03/2012 | US20120107317 Use of cytoplasmic c-myc for regulating immune responses |
05/03/2012 | US20120107297 Method for therapeutic angiogenesis |
05/03/2012 | US20120107291 Bifidobacteria for treating diabetes and related conditions |
05/03/2012 | US20120107284 Stem cells for transplantation and methods for production thereof |
05/03/2012 | US20120107281 Compositions and methods for modifying cell surface glycans |
05/03/2012 | US20120107269 Thiophene derivatives |
05/03/2012 | US20120107230 Treatment of Hyperproliferative Diseases with Vinca Alkaloid N-Oxide Analogs |
05/03/2012 | US20120107229 Novel nano-probes for molecular imaging and targeted therapy of diseases |
05/03/2012 | DE102010043318A1 Calciumcarbonat enthaltende Zusammensetzung Calcium carbonate-containing composition |
05/03/2012 | DE102008062136B4 Pharmazeutische Zusammensetzung auf Basis von Peptid aus Kamelmilch A pharmaceutical composition based on peptide from camel milk |
05/03/2012 | CA2856153A1 Peptide |
05/03/2012 | CA2816088A1 Metalloenzyme inhibitor compounds |
05/03/2012 | CA2814846A1 Cyclic amine substituted oxazolidinone cetp inhibitor |
05/03/2012 | CA2814768A1 Oxazoline and isoxazoline derivatives as crac modulators |
05/03/2012 | CA2814752A1 Diazeniumdiolate heterocyclic derivatives |
05/02/2012 | EP2447265A1 Novel thiophene carboxamide derivative and medicinal use of same |
05/02/2012 | EP2447264A1 N-substituted-cyclic amino derivative |
05/02/2012 | EP2447257A1 Drug for inhibiting lectin-like oxidized ldl receptor and drug for preventing arteriosclerosis |
05/02/2012 | EP2447254A1 Crystals |
05/02/2012 | EP2446929A1 Microvesicles derived from atheroprotective endothelial cells for the treatment and prevention of atherosclerotic diseases |
05/02/2012 | EP2446902A1 Methods for treating conditions associated with MASP-2 dependent complement activation |
05/02/2012 | EP2446901A1 Methods for treating conditions associated with MASP-2 dependent complement activation |
05/02/2012 | EP2446900A1 Methods for treating conditions associated with MASP-2 dependent complement activation |
05/02/2012 | EP2446885A1 Therapeutic agent for hypertension or normal high blood pressure |
05/02/2012 | EP2446883A1 Treatment of inflammation |
05/02/2012 | EP2446879A2 Pharmaceutical composition containing carboxylosartan and a production method therefor |
05/02/2012 | EP2445861A1 Novel acetylsalicylic acid salts |
05/02/2012 | EP2445505A1 Combined use of creatine phosphate and creatine phosphokinase for treatment of arteriosclerosis |
05/02/2012 | EP2445339A1 Diffusion enhancing compounds and their use alone or with thrombolytics |
05/02/2012 | EP1861403B1 Novel imidazo[1,5-a]pyridine derivatives, method for preparing same and pharmaceutical compositions containing same |
05/02/2012 | EP1860114B1 Nitroguanosine-3 ,5 -cyclic monophosphate and protein kinase g activator |
05/02/2012 | EP1693060B1 Therapeutic or preventive agents for ischemic neuropathy |
05/02/2012 | EP1534668B1 Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid |
05/02/2012 | EP1517905B1 Processes for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinases |
05/02/2012 | EP1487431B1 Preventing and/or treating cardiovascular disease and/or associated heart failure |
05/02/2012 | EP1418893B1 Compositions and techniques for localized therapy of restenosis |
05/02/2012 | EP1415992B1 Diamine derivatives |
05/02/2012 | EP1389130B1 Use of osteopontin for the treatment and/or prevention of neurologic diseases |
05/02/2012 | EP1032403B1 Nutritional supplement for cerebral metabolic insufficiencies |
05/02/2012 | CN202207316U Apparatus for treating heart meridian tissue diseases through traditional Chinese medicine |
05/02/2012 | CN102439035A Immunomodulatory methods and systems for treatment and/or prevention of atherosclerosis and related proteins, peptides and compositions |
05/02/2012 | CN102439007A Amide derivative |
05/02/2012 | CN102438991A Carbinol compound having heterocyclic linker |
05/02/2012 | CN102438990A Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof |
05/02/2012 | CN102438986A Isoquinolin-1 (2h) -one derivatives as parp-1 inhibitors |
05/02/2012 | CN102438625A Pharmaceutical composition for neuroprotective treatment in patients with ictus comprising citicoline and uric acid |
05/02/2012 | CN102438624A Substituted fused pyrimidine compounds |
05/02/2012 | CN102438614A Pyrone analogs for therapeutic treatment |
05/02/2012 | CN102432760A Quaternary amine konjac glucomannan adduct, its preparation method and application |
05/02/2012 | CN102432690A Application of Opuntia ficus-indica Milpa Alta polysaccharides to prevention and treatment of chronic neurodegenerative disease |
05/02/2012 | CN102432670A Silkworm chrysalis protein source dipeptide SS and application thereof |
05/02/2012 | CN102432599A Crystal form of oxalate of dipeptidyl peptidase inhibitor and preparation method and application thereof |
05/02/2012 | CN102432540A Novel preparation method and use of bisedaravone and medicinal salts of bisedaravone |
05/02/2012 | CN102432467A Salvianolic acid A magnesium salt, preparation method and use of the salvianolic acid A magnesium salt, and salvianolic acid A magnesium salt-containing freeze-dried powder injection composition |
05/02/2012 | CN102430117A Modified proteases that inhibit complement activation |
05/02/2012 | CN102430110A CAlprostadil composite medicament of compound fermented cordyceps sinensis powder and alprostadil composite drug |
05/02/2012 | CN102430109A Amlodipine, aliskiren and pril compound antihypertensive medicament |
05/02/2012 | CN102430102A Preparation method for huangqi-guizhi-wuwu granule |
05/02/2012 | CN102430094A Traditional Chinese medicine decoction for treating angina pectoris |
05/02/2012 | CN102430090A Traditional Tibetan medicine Ruyizhenbao composite preparation and preparation method thereof |
05/02/2012 | CN102430088A Formula and preparation process of multifunctional Chinese herbal medicine bag |
05/02/2012 | CN102430086A Traditional Chinese medicine composition with function of tonifying qi of kidneys and preparation method thereof |
05/02/2012 | CN102430085A Chinese medicine for treating coronary heart disease |
05/02/2012 | CN102430067A Method for preparing medicament for treating hypertension |
05/02/2012 | CN102430063A Process for extracting general flavone in reed leaves by supercritical CO2 method |
05/02/2012 | CN102430060A Cold and hot temperature difference method for processing tall gastrodia tuber |
05/02/2012 | CN102430056A Medicament for treating hypertension |
05/02/2012 | CN102430029A Nano microcapsule for six ingredients with rehmannia and preparation process thereof |
05/02/2012 | CN102429952A Application of humifuse euphorbia herb ethanol extract to preparation of vascular dilation medicament |
05/02/2012 | CN102429944A Medicinal active ingredient for treating cardiac and cerebral thrombosis diseases and application thereof |
05/02/2012 | CN102429943A Sugar-free erigeron breviscapus mixture and preparation method thereof |
05/02/2012 | CN102429932A Method for extracting lucid ganoderma essence |
05/02/2012 | CN102429931A Compound fermented cordyceps fungus powder salvianic acid combined drug |
05/02/2012 | CN102429928A Preparation method for coix seed red yeast rice |
05/02/2012 | CN102429919A Water-soluble vitamin combination medicine |
05/02/2012 | CN102429916A Substances mixture, use and infusion solution |
05/02/2012 | CN102429911A Application of ZSTK474 to preparation of medicine for treating autoimmune diseases |
05/02/2012 | CN102429908A Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases |
05/02/2012 | CN102429903A Ozagrel sodium medicinal composition for injection |
05/02/2012 | CN102429897A Pharmaceutical composition for improving oral bioavailability of morin |
05/02/2012 | CN102429886A Indapamide osmotic pump preparation and preparation method thereof |
05/02/2012 | CN102429874A Nifedipine framework sustained-release pellets and preparation method and application thereof |
05/02/2012 | CN102429858A Preparation method and application of sustained-release BIO/IGF (6-bromoindirubin-3'-oxime/insulin-like growth factor) composite hydrogel |
05/02/2012 | CN102119957B Preparation method and application of effective ingredient of rosewood heart wood |
05/02/2012 | CN102106979B Medicament for treating hypertension |
05/02/2012 | CN102068440B Drug composition for treating cardio-cerebrovascular diseases and preparation method |
05/02/2012 | CN102038639B Alprostadil injection preparation |
05/02/2012 | CN102008571B Traditional Chinese medicine composition as well as preparation method and application thereof |
05/02/2012 | CN101972260B Rosuvastatin calcium oral drug composition |
05/02/2012 | CN101961403B Combined Chinese medicinal ointment for treating hemorrhoids |
05/02/2012 | CN101912491B Pills for treating cardiovascular diseases and preparation method |
05/02/2012 | CN101804141B Chinese medicine compound for preventing and curing hypertension, hyperlipidemia, hyperglycemia and complications thereof |
05/02/2012 | CN101766674B Medicament composition for preventing and controlling restenosis after intracoronary stent implantation |
05/02/2012 | CN101732408B Chinese medicament for treating angitis and limb angiopathy and preparation method thereof |